The global biopharmaceutical excipients market size is expected to reach USD 3.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.50% from 2023 to 2030. The increasing focus of pharmaceutical players on the generic market, rising adoption of multifunctional excipients, and patent expiry of biological actives are the key factors propelling market growth. Furthermore, the cost-efficiency & competency of manufacturers and the chemical and physical instability of biopharmaceuticals are boosting the development of excipients, thus propelling the market.

The demand for biosimilars has increased in recent years, which has in turn led to a rise in the demand for biopharmaceutical excipients. Supporting factors such as patent expirations, increasing government funding, patient demographics, and rising affordability have propelled the adoption of biosimilars across the globe. In addition, the rapidly evolving healthcare infrastructure in developing economies has increased their use in the production of biogenerics. Furthermore, the introduction of well-framed legislation to ensure proper regulatory and testing standards for biosimilars globally is set to ease market entry for manufacturers.

Gather more insights about the market drivers, restrains and growth of the Global Biopharmaceutical Excipients Market

Biopharmaceutical Excipients Market Report Highlights

  • Thecarbohydrate-based products segment dominated the market for biopharmaceutical excipients in 2022 with a revenue share of 35.80%, and this trend is expected to continue through the forecast period. The extensive use of starch, sucrose, and dextrose in various drug formulations can be primarily attributed to the dominant share of the segment
  • The polyols segment is expected to witness the fastest CAGR of 5.77% during the projection period. Polyols are sugar alcohols found in certain fruits, vegetables, and sugar-free sweeteners. The segment growth can be attributed to the increasing demand for protein therapeutics. Polyols are added in protein formulations for increasing tonicity and stability
  • In terms of region, North America held the highest share in the market for biopharmaceutical excipients in 2022.The regional growth can be attributed to several factors such as the presence of key players, increasing drug development, and a large population base. Companies in this region are collaborating frequently to develop biopharmaceutical excipients
  • In Asia Pacific, the market is expected to witness the fastest growth rate of over 6.0% during the forecast period, owing to the presence of large CMOs involved in drug development in the region. Countries such as China, India, and South Korea are majorly involved in the development of biosimilars. There are several reasons for the extensive development of biosimilars in this region, such as affordability, favorable regulatory framework, cost advantages, and the presence of a large population base

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Medical Foods Market: The global medical foods market size was estimated at USD 24.80 billion in 2024 and is projected to grow at a CAGR of 5.13% from 2025 to 2030.
  • Kidney Cancer Drugs Market: The global kidney cancer drugs market size was valued at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2030.

Biopharmaceutical Excipients Market Segmentation

Grand View Research has segmented the global biopharmaceutical excipients market on the basis of product, and region:

Biopharmaceutical Excipients Product Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)

  • Solubilizes & Surfactants/Emulsifiers
    • Triglycerides
    • Esters
    • Others
  • Polyols
    • Mannitol
    • Sorbitol
    • Others
  • Carbohydrates
    • Sucrose
    • Dextrose
    • Starch
    • Others
  • Specialty Excipients

Biopharmaceutical Excipients Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 – 2030)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Order a free sample PDF of the Biopharmaceutical Excipients Market Intelligence Study, published by Grand View Research.